Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patients


Bisgin A., Yalcin A. D. , Gorczynski R. M.

DIABETES RESEARCH AND CLINICAL PRACTICE, vol.96, no.3, 2012 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 96 Issue: 3
  • Publication Date: 2012
  • Doi Number: 10.1016/j.diabres.2012.02.028
  • Title of Journal : DIABETES RESEARCH AND CLINICAL PRACTICE

Abstract

We examined the association between serum sTRAIL measured by ELISA and HbA1C levels, pre/post-prandial blood glucose levels and body mass index in 22 newly diagnosed type-2 diabetic patients.